ADAM10 is upregulated in melanoma metastasis compared with primary melanoma.
about
Clinical significance of ADAM10 expression in laryngeal carcinoma.PAX2 regulates ADAM10 expression and mediates anchorage-independent cell growth of melanoma cellsSoluble E-cadherin: more than a symptom of disease.Inhibiting adenoid cystic carcinoma cells growth and metastasis by blocking the expression of ADAM 10 using RNA interference.The Roles of ADAMs Family Proteinases in Skin DiseasesProstaglandins in cancer cell adhesion, migration, and invasionADAM10: a new player in breast cancer progression?Notch1 Autoactivation via Transcriptional Regulation of Furin, Which Sustains Notch1 Signaling by Processing Notch1-Activating Proteases ADAM10 and Membrane Type 1 Matrix MetalloproteinaseThe use of an in vitro 3D melanoma model to predict in vivo plasmid transfection using electroporation.Effects of ADAM10 upregulation on progression, migration, and prognosis of nasopharyngeal carcinoma.L1cam promotes tumor progression and metastasis and is an independent unfavorable prognostic factor in gastric cancerThe ADAMs family of proteases as targets for the treatment of cancer.Reduced Proteolytic Shedding of Receptor Tyrosine Kinases Is a Post-Translational Mechanism of Kinase Inhibitor ResistanceADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis.Galectin-9 is a suppressor of T and B cells and predicts the immune modulatory potential of mesenchymal stromal cell preparationsDesmoplasia: not always a bad thing.Tetraspanin protein contributions to cancer.Identification of Nidogen 1 as a lung metastasis protein through secretome analysis.L1 cell adhesion molecule as a therapeutic target in cancer.Effect of A disintegrin and metalloproteinase 10 gene silencing on the proliferation, invasion and migration of the human tongue squamous cell carcinoma cell line TCA8113.ADAM10 correlates with uveal melanoma metastasis and promotes in vitro invasion.ADAM10 regulates proliferation, invasion, and chemoresistance of bladder cancer cells.ADAM 10 is over expressed in oral squamous cell carcinoma and contributes to invasive behaviour through a functional association with αvβ6 integrin.Multi-omics Analysis of Serum Samples Demonstrates Reprogramming of Organ Functions Via Systemic Calcium Mobilization and Platelet Activation in Metastatic Melanoma.ADAM10 overexpression confers resistance to doxorubicin-induced apoptosis in hepatocellular carcinoma.MicroRNA-145 targets the metalloprotease ADAM17 and is suppressed in renal cell carcinoma patientsADAM12-L confers acquired 5-fluorouracil resistance in breast cancer cellsThe disintegrin/metalloproteinase Adam10 is essential for epidermal integrity and Notch-mediated signaling.Aberrant ADAM10 expression correlates with osteosarcoma progression.Regulation of ADAM10 by miR-140-5p and potential relevance for Alzheimer's disease.Insulin-like growth factor-1 activates different catalytic subunits p110 of PI3K in a cell-type-dependent manner to induce lipogenesis-dependent epithelial-mesenchymal transition through the regulation of ADAM10 and ADAM17.The B7 Family Member B7-H6: a New Bane of Tumor.TSPAN15 interacts with BTRC to promote oesophageal squamous cell carcinoma metastasis via activating NF-κB signaling.The transcription factor PAX2 regulates ADAM10 expression in renal cell carcinoma.A disintegrin and metalloprotease (ADAM)10 is highly expressed in hepatocellular carcinoma and is associated with tumour progression.High percentage of ADAM-10 positive melanoma cells correlates with paucity of tumor-infiltrating lymphocytes but does not predict prognosis in cutaneous melanoma patients.Cellular sheddases are induced by Merkel cell polyomavirus small tumour antigen to mediate cell dissociation and invasiveness
P2860
Q33597779-28991314-A83A-4559-953E-1F8ED9EA356FQ34005367-F3DDA6F6-7258-4E7E-B571-7E2934610F26Q34279705-9F49C2A9-6608-4FDB-99EC-B661A602EC44Q34473664-425FB3BD-FD24-48F9-9964-57EC2BEB68DEQ34669802-25B93870-AE35-4BC2-9272-5884A6F75C5FQ35821653-21D5F815-DB3C-49B6-B21B-134339659CAEQ36081396-CFB25733-C316-490E-9CD5-3E0734F0B813Q36109377-2CB0D281-55E5-4208-AFE9-97F187D74139Q36303149-3274093D-96E2-4A40-9CF6-2DFCC9CBCAFDQ36467413-010347BD-8197-444F-ADCA-A18E36EAA941Q37028791-5CFEFB6C-4147-4B72-A369-698AF290F798Q37216972-A9AD3E20-76C3-4800-8760-A1A376F3FB07Q37380418-C06BE0DC-8EF3-49CC-8374-F86FAE96319EQ37591124-0E0285AA-D39C-48BE-964E-8690F0A7B231Q37667547-BFD9C153-6D1D-4F3B-8140-E1B3B784FD99Q37780799-4F71339F-69F2-405A-92CC-449E542EDEFFQ37856398-4D3E60DB-11EC-4EAB-80AF-BFBFDA2FF2CBQ38615448-612D0ADD-BDC5-485D-83BB-7C7548274F1DQ38701631-A51297AF-CD61-47E4-B21C-2E4967975560Q38946216-D8DE34AD-BCC1-4116-833B-8B18F5D7F403Q38965918-AD0CC727-5E8D-4382-807E-64AB37CE1948Q38984070-92C53A24-9D81-4718-8687-6B32F21C46E6Q39093483-E8A45E41-67E4-44B6-A4EA-8B2B212A4E02Q39159735-3F54F063-457D-42FA-9E3C-17A9824F22AEQ39348959-D0AB4908-E6F6-4CD0-B28C-844D45C0AD3DQ41412889-7FD70A9B-8EA8-4AD3-A2EB-399A5AF4D53EQ41548025-DF0CDD50-1172-4984-B20E-31AF8DC55807Q41602986-1C870BFC-335D-466A-9A44-0358CC79E295Q41982806-1EF86C07-3E3B-451E-8FA9-BA81378F3F0AQ47908768-E214D1BF-88C4-43F8-85C4-2BF3240F8BCCQ47936787-38A18104-8449-4B94-9991-D104444E6D5BQ48098708-D5EA9A84-E906-47DC-941D-8C69A47428B9Q52590985-51CE3AAB-F6C5-4B20-A440-57B8C1E6B77AQ53222639-F7660DCF-6A8B-46CB-A976-9B0EE41650A7Q54216177-5C6E7E4B-4747-401F-B735-401E3D3AD69CQ54310179-23BFC1BF-41A0-4837-924F-56567AAE8657Q58761272-522A9B66-09B6-4047-A361-CE47B210F73A
P2860
ADAM10 is upregulated in melanoma metastasis compared with primary melanoma.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
ADAM10 is upregulated in melanoma metastasis compared with primary melanoma.
@ast
ADAM10 is upregulated in melanoma metastasis compared with primary melanoma.
@en
type
label
ADAM10 is upregulated in melanoma metastasis compared with primary melanoma.
@ast
ADAM10 is upregulated in melanoma metastasis compared with primary melanoma.
@en
prefLabel
ADAM10 is upregulated in melanoma metastasis compared with primary melanoma.
@ast
ADAM10 is upregulated in melanoma metastasis compared with primary melanoma.
@en
P2093
P356
P1476
ADAM10 is upregulated in melanoma metastasis compared with primary melanoma
@en
P2093
Anja Schramme
Daniel Oxmann
Daniela Mihic-Probst
Josef Pfeilschifter
Jörg Reichrath
Paul Gutwein
Peter Altevogt
Reinhard Dummer
Sascha Keller
P2888
P304
P356
10.1038/JID.2009.335
P407
P577
2009-10-29T00:00:00Z